Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Bodal Chemicals Ltd (BODALCHEM)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524370 NSE: BODALCHEM Dyes & Pigments | Small Cap | Bodal Chemicals Share Price
₹201.80 6.75 (3.46%)
As on 25-Sep'26 16:59
Bodal Chemicals Ltd (BODALCHEM)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524370 NSE: BODALCHEM Dyes & Pigments | Small Cap | Bodal Chemicals Share Price
₹201.80 6.75 (3.46%)
As on 25-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹2,542 Cr.
Current Price
₹201.8
52-Week Low / High
₹41 / 206
TTM EPS
₹5.5
TTM Sales
₹2,267 Cr.
Book Value per Share
₹94.3
P/E Ratio
37.01
Higher than its 5-year historical median
Industry PE
3.9
Price to Book (P/B)
2.14
Higher than its 5-year historical median
Price to Sales (P/S)
1.12
Higher than its 5-year historical median
EV/EBITDA
14.67
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
4.23%
Underperforms industry median
Return on Capital Employed (ROCE)
6.71%
Underperforms industry median
Return on Assets (ROA)
2.05%
Operating Profit Margin
8.8%
Net Profit Margin
2.38%
Gross Profit Margin
6.1%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
14.36%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-2.34%
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
158.54%
Asset Quality
Promoter Holding
57.00%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹1,163 Cr.
Equity
₹25.2 Cr.
Face Value
₹2
All Time Low / High
₹0.04 / 205.70
Check Before You Invest
Quality
Not GoodValuation
FairCheck Valuation charts
Price Trend
Strong
Is Bodal Chemicals Ltd a good quality company?
Bodal Chemicals Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Bodal Chemicals Ltd performance compare with that of its Peers?
Revenue growth of Bodal Chemicals Ltd vs industry peers?
Bodal Chemicals Ltd revenue CAGR is 10.41%, compared to the industry median CAGR of 0.97%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Bodal Chemicals Ltd?
Promoters hold 57.00% of the Bodal Chemicals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Bodal Chemicals Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 3.7% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bodal Chemicals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 47.4% | 29.2% | 25.2% | 11.2% | 5.6% | 11.8% | 4.3% | 3.3% | 5.2% | 6.8% | - |
| Value Creation Index ⓘ | 2.4 | 1.1 | 0.8 | -0.2 | -0.6 | -0.2 | -0.7 | -0.8 | -0.6 | -0.5 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 1,182 | 1,121 | 1,379 | 1,224 | 1,130 | 2,011 | 1,555 | 1,386 | 1,727 | 1,975 | 2,228 |
| Sales YoY Gr. | - | -5.2% | 23.1% | -11.3% | -7.7% | 78% | -22.7% | -10.9% | 24.5% | 14.4% | - |
| Adj EPS ⓘ | 11.4 | 10.1 | 11.9 | 7.9 | 3.7 | 10 | 2.9 | 0.2 | 1.8 | 2.8 | 5.2 |
| YoY Gr. | - | -11.4% | 17.5% | -33.4% | -52.8% | 166% | -70.9% | -94.5% | 993.8% | 60.6% | - |
| BVPS (₹) ⓘ | 33.2 | 57.4 | 68.2 | 73 | 81 | 90 | 89.6 | 90 | 91.5 | 95.2 | 97.5 |
| Adj Net Profit ⓘ | 125 | 124 | 145 | 97 | 45.8 | 122 | 36.4 | 2.1 | 22 | 35.4 | 65 |
| Cash Flow from Ops. ⓘ | 112 | 22.1 | 210 | 65.5 | -21.6 | 29.8 | 246 | 191 | 106 | 177 | - |
| Debt/CF from Ops. ⓘ | 1.3 | 6.7 | 0.7 | 3.6 | -20.2 | 21.5 | 3.1 | 4.7 | 8.6 | 4.5 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 5.9% | 11.8% | 8.3% | 14.4% | ||||
| Adj EPS ⓘ | -14.4% | -5.6% | -1.1% | 60.6% | ||||
| BVPSⓘ | 12.4% | 3.3% | 2.1% | 4.1% | ||||
| Share Price | 3.7% | 13.2% | 35.2% | 223% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 41.4 | 23.3 | 18.9 | 11 | 4.7 | 11.6 | 3.3 | 0.2 | 1.9 | 3 | 5.4 |
| Op. Profit Mgn % ⓘ | 18.7 | 17.6 | 17 | 11.7 | 7.4 | 11.2 | 8.4 | 7.8 | 10 | 9 | 8.4 |
| Net Profit Mgn % ⓘ | 10.6 | 11.1 | 10.5 | 7.9 | 4.1 | 6.1 | 2.3 | 0.2 | 1.3 | 1.8 | 2.9 |
| Debt to Equity ⓘ | 0.4 | 0.2 | 0.2 | 0.3 | 0.4 | 0.6 | 0.7 | 0.8 | 0.8 | 0.7 | - |
| Working Cap Days ⓘ | 111 | 167 | 164 | 210 | 265 | 184 | 238 | 227 | 183 | 172 | 75 |
| Cash Conv. Cycle ⓘ | 36 | 66 | 69 | 89 | 126 | 100 | 137 | 119 | 91 | 84 | 9 |
Valuation of Bodal Chemicals - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,234 | 1,142 | 1,424 | 1,375 | 1,226 | 2,055 | 1,574 | 1,395 | 1,748 | 2,012 |
| Operating Expenses ⓘ + | 1,008 | 948 | 1,187 | 1,237 | 1,140 | 1,835 | 1,441 | 1,300 | 1,586 | 1,854 |
| Operating Profit ⓘ | 226 | 194 | 236 | 138 | 87 | 220 | 133 | 94 | 162 | 159 |
| Operating Profit Margin (%) | 18.3% | 17.0% | 16.6% | 10.0% | 7.1% | 10.7% | 8.5% | 6.8% | 9.3% | 7.9% |
| Other Income ⓘ + | 11 | 9 | 13 | 10 | 16 | 17 | 12 | 25 | 8 | 44 |
| Interest ⓘ | 9 | 5 | 9 | 19 | 17 | 29 | 41 | 54 | 82 | 79 |
| Depreciation ⓘ | 29 | 12 | 21 | 28 | 30 | 47 | 53 | 60 | 69 | 70 |
| Profit Before Tax ⓘ | 204 | 186 | 219 | 101 | 55 | 142 | 51 | 5 | 19 | 54 |
| Tax ⓘ | 71 | 62 | 77 | 15 | 16 | 43 | 13 | -2 | 1 | 7 |
| Profit After Tax | 133 | 125 | 142 | 86 | 40 | 99 | 38 | 6 | 19 | 48 |
| PAT Margin (%) | 10.8% | 10.9% | 10.0% | 6.3% | 3.2% | 4.8% | 2.4% | 0.5% | 1.1% | 2.4% |
| Adjusted EPS (₹) | 12.2 | 10.0 | 11.7 | 7.1 | 3.4 | 8.5 | 3.0 | 0.5 | 1.5 | 3.8 |
| Dividend Payout Ratio (%) | 6.60% | 8% | 6.80% | 11.20% | 23.30% | 9.40% | 3.30% | 0% | 0% | 0% |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 363 | 697 | 828 | 887 | 979 | 1,051 | 1,076 | 1,081 | 1,105 | 1,158 | |
| Debt + | 149 | 181 | 169 | 256 | 453 | 675 | 693 | 803 | 792 | 659 | |
| Minority Interest | 2 | 1 | 1 | 7 | 5 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 159 | 152 | 222 | 210 | 222 | 255 | 178 | 195 | 236 | 247 | |
| Others Liabilities ⓘ | 34 | 41 | 71 | 96 | 89 | 131 | 174 | 201 | 207 | 273 | |
| Total Liabilities ⓘ | 707 | 1,072 | 1,290 | 1,455 | 1,749 | 2,113 | 2,120 | 2,281 | 2,339 | 2,336 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 222 | 437 | 609 | 656 | 804 | 817 | 967 | 1,314 | 1,301 | 1,239 | |
| CWIP ⓘ | 9 | 19 | 26 | 7 | 14 | 70 | 193 | 68 | 61 | 67 | |
| Investments ⓘ | 17 | 17 | 6 | 3 | 6 | 0 | 0 | 13 | 0 | 0 | |
| Inventories | 131 | 113 | 208 | 219 | 307 | 445 | 293 | 267 | 337 | 324 | |
| Trade Receivables | 230 | 347 | 330 | 454 | 468 | 590 | 420 | 381 | 399 | 439 | |
| Cash Equivalents | 17 | 6 | 10 | 20 | 16 | 15 | 19 | 33 | 36 | 21 | |
| Others Assets ⓘ | 81 | 134 | 103 | 97 | 132 | 177 | 228 | 205 | 205 | 247 | |
| Total Assets ⓘ | 707 | 1,072 | 1,290 | 1,455 | 1,749 | 2,113 | 2,120 | 2,281 | 2,339 | 2,336 | |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 104 | 7 | 186 | 10 | -13 | -14 | 290 | 204 | 114 | 176 |
| Cash Flow From Investing Activity ⓘ + | -68 | -256 | -128 | -81 | -168 | -170 | -310 | -262 | -37 | 11 |
| Cash Flow From Financing Activity ⓘ + | -23 | 236 | -51 | 76 | 178 | 181 | 33 | 81 | -73 | -191 |
| Net Cash Flow ⓘ | 13 | -13 | 7 | 5 | -3 | -3 | 12 | 24 | 3 | -5 |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 44.51 | 23.52 | 18.66 | 10.04 | 4.26 | 9.72 | 3.58 | 0.6 | 1.69 | 4.23 |
| ROCE (%) | 47.7 | 27.56 | 24.3 | 10.94 | 5.49 | 10.85 | 5.15 | 3.09 | 5.06 | 6.71 |
| Asset Turnover Ratio | 2.2 | 1.31 | 1.21 | 1 | 0.77 | 1.06 | 0.75 | 0.64 | 0.76 | 0.87 |
| PAT to CFO Conversion(x) | 0.78 | 0.06 | 1.31 | 0.12 | -0.33 | -0.14 | 7.63 | 34 | 6 | 3.67 |
| Working Capital Days | ||||||||||
| Receivable Days | 54.10 | 90.30 | 86.70 | 104.10 | 137.20 | 93.90 | 116 | 104.20 | 81.10 | 75.50 |
| Inventory Days | 30.10 | 38.20 | 41.20 | 56.60 | 78.30 | 66.80 | 84.60 | 72.80 | 62.90 | 59.50 |
| Payable Days | 60.40 | 80.40 | 77 | 89.20 | 99.20 | 75.70 | 88.20 | 97.30 | 88.90 | 79.40 |
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Bodal Chemicals Ltd FAQs
The current trading price of Bodal Chemicals on 25-Sep-2026 16:59 is ₹201.8.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Sep-2026 the market cap of Bodal Chemicals stood at ₹2,541.6 Cr
The latest P/E ratio of Bodal Chemicals as of 24-Sep-2026 is 38.81.
The latest P/B ratio of Bodal Chemicals as of 24-Sep-2026 is 2.07.
The 52-week high of Bodal Chemicals is ₹205.7 and the 52-week low is ₹41.25.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Bodal Chemicals is ₹2,228 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Bodal Chemicals Ltd is a below average quality company.
The key valuation ratios of Bodal Chemicals Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Bodal Chemicals Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing
About Bodal Chemicals Ltd
Bodal Chemicals formaly known as JK phrarma, 17 years of success saga. The quest begin in 1989 with two enterprising young men Suresh patel and Ramesh patel, willing to take on the world of chemicals with their quality offering. And thus began JK pharma, a partnership firm with the production capacity of 60 metric tonnes per annum of Vinyl Sulphone. Bodal Chemicals Ltd has now emerged as supplier of one of the finest quality of Dyes and Dyes Intermediates
The company's huge motivation is the ability to use its products in the most optimum way and it has made it to lead from one partnership firm to a well established Limited Company. 1994 saw the conversion of the partnership firm to a private limited company with the change in name to Bodal Chemicals Ltd.
About 17 years back company started producing vinyl sulphone in a small way and with the passage of time due to foresight of the main person instrumental, Today Bodal is producing about 12 major dye intermediates with a monthly capacity of 1500 mt.
For the production of dyes the company has their own major dye-intermediates means quality will be consistent of dye_stuffs. Bodal is a fast growing company in the field of manufacturing dye intermediates & dye stuffs.
Bodal chemicals have established their production units at
- Bodal Chemicals Ltd, Ahmedabad - Unit 1
- Bodal Chemicals Ltd, Ahmedabad - Unit 2
- Bodal Chemicals Ltd, Ahmedabad - Unit 3
- Bodal Chemicals Ltd, Ahmedabad - Unit 4
- Bodal Chemicals Ltd, Ankleshwar - Unit 5
- Bodal Chemicals Ltd, Panoli - Unit 6
- Bodal Chemicals Ltd, Baroda - Unit 7
Product range of the company includes:
Dyes intermediates
Acid & Direct Dyes
- Direct Dyes
- Acid Miling Dyes
- Metal Complex Dyes Acid 1:1
- Metal Complex Dyes Acid 2:1
- Acid Dyes
Reactive Dyes
- VS Based Dyes
- H Dyes
- HE Dyes
- M Dyes
- Bifunctional Dyes
Out of total production more than 70% is being exported to various countries like USA, UK, Germany, Spain, Turkey, China, Indonasia, Taiwan, Korea, Greece, Egypt, Portugal, Hongkong, Italy, Bangladesh and Pakistan.
Awards/achievements
- Bodal Chemicals is an ISO 9001-2000 certified company
- The company has Received Award for Excellence Growth in Exports from Mr. R S Reddy, Executive Director of Union Bank of India on 11/09/2006.
- The company is a Government of India recognized Export House.
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
